» Articles » PMID: 33791076

Melatonin to Rescue the Aged Heart: Antiarrhythmic and Antioxidant Benefits

Overview
Publisher Wiley
Date 2021 Apr 1
PMID 33791076
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Aging comes with gradual loss of functions that increase the vulnerability to disease, senescence, and death. The mechanisms underlying these processes are linked to a prolonged imbalance between damage and repair. Damaging mechanisms include oxidative stress, mitochondrial dysfunction, chronodisruption, inflammation, and telomere attrition, as well as genetic and epigenetic alterations. Several endogenous tissue repairing mechanisms also decrease. These alterations associated with aging affect the entire organism. The most devastating manifestations involve the cardiovascular system and may lead to lethal cardiac arrhythmias. Together with structural remodeling, electrophysiological and intercellular communication alterations during aging predispose to arrhythmic events. Despite the knowledge on repairing mechanisms in the cardiovascular system, effective antiaging strategies able to reduce the risk of arrhythmias are still missing. Melatonin is a promising therapeutic candidate due to its pleiotropic actions. This indoleamine regulates chronobiology and endocrine physiology. Of relevance, melatonin is an antiaging, antioxidant, antiapoptotic, antiarrhythmic, immunomodulatory, and antiproliferative molecule. This review focuses on the protective effects of melatonin on age-induced cardiac functional and structural alterations, potentially becoming a new fountain of youth for the heart.

Citing Articles

Cartilage defect repair in a rat model via a nanocomposite hydrogel loaded with melatonin-loaded gelatin nanofibers and menstrual blood stem cells: an in vitro and in vivo study.

Yuan L, Yao L, Ren X, Chen X, Li X, Xu Y J Mater Sci Mater Med. 2024; 35(1):55.

PMID: 39347832 PMC: 11442572. DOI: 10.1007/s10856-024-06820-z.


Melatonin alleviates aging-related heart failure through melatonin receptor 1A/B knockout in mice.

Feng Z, Liu Y, Yang Y, Bai J, Lin Q, Xia Y Heliyon. 2024; 10(18):e38098.

PMID: 39347399 PMC: 11437847. DOI: 10.1016/j.heliyon.2024.e38098.


Melatonin Ameliorates Ovarian Hyperstimulation Syndrome (OHSS) through SESN2 Regulated Antiapoptosis.

Zheng M, Liu M, Zhang C Obstet Gynecol Int. 2023; 2023:1121227.

PMID: 37937274 PMC: 10626722. DOI: 10.1155/2023/1121227.


Arrhythmia related to hypertensive left ventricular hypertrophy in Iraqi patients: frequency and outcome.

Al Alwany A J Med Life. 2022; 15(9):1115-1118.

PMID: 36415521 PMC: 9635237. DOI: 10.25122/jml-2022-0214.


Antioxidants in Arrhythmia Treatment-Still a Controversy? A Review of Selected Clinical and Laboratory Research.

Szyller J, Jagielski D, Bil-Lula I Antioxidants (Basel). 2022; 11(6).

PMID: 35740006 PMC: 9220256. DOI: 10.3390/antiox11061109.


References
1.
Trebak M, Ginnan R, Singer H, Jourdheuil D . Interplay between calcium and reactive oxygen/nitrogen species: an essential paradigm for vascular smooth muscle signaling. Antioxid Redox Signal. 2009; 12(5):657-74. PMC: 2861541. DOI: 10.1089/ars.2009.2842. View

2.
Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D . Oxidative stress, aging, and diseases. Clin Interv Aging. 2018; 13:757-772. PMC: 5927356. DOI: 10.2147/CIA.S158513. View

3.
Dzida G, Prystupa A, Lachowska-Kotowska P, Kadas T, Kamienski P, Kimak E . Alteration in diurnal and nocturnal melatonin serum level in patients with chronic heart failure. Ann Agric Environ Med. 2013; 20(4):745-8. View

4.
Huang X, Yang P, Du Y, Zhang J, Ma A . Age-related down-regulation of HCN channels in rat sinoatrial node. Basic Res Cardiol. 2007; 102(5):429-35. DOI: 10.1007/s00395-007-0660-5. View

5.
Baba K, Benleulmi-Chaachoua A, Journe A, Kamal M, Guillaume J, Dussaud S . Heteromeric MT1/MT2 melatonin receptors modulate photoreceptor function. Sci Signal. 2013; 6(296):ra89. PMC: 3867265. DOI: 10.1126/scisignal.2004302. View